162 related articles for article (PubMed ID: 7585517)
1. Riboflavin-mediated photosensitization of Vinca alkaloids distorts drug sensitivity assays.
Granzow C; Kopun M; Kröber T
Cancer Res; 1995 Nov; 55(21):4837-43. PubMed ID: 7585517
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR of vinca alkaloid analogues.
Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
[TBL] [Abstract][Full Text] [Related]
3. Increased sensitivity to Vinca alkaloids in cells overexpressing calmodulin by gene transfection.
Ido M; Lagacé L; Chafouleas JG
Cancer Res; 1990 Oct; 50(20):6554-8. PubMed ID: 2208115
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity determination without photochemical artifacts.
Heuser M; Kopun M; Rittgen W; Granzow C
Cancer Lett; 2005 Jun; 223(1):57-66. PubMed ID: 15890237
[TBL] [Abstract][Full Text] [Related]
5. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
Ono M; Tanaka N
In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
[TBL] [Abstract][Full Text] [Related]
6. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
[TBL] [Abstract][Full Text] [Related]
7. New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies.
Orosz F; Comin B; Raïs B; Puigjaner J; Kovács J; Tárkányi G; Acs T; Keve T; Cascante M; Ovádi J
Br J Cancer; 1999 Mar; 79(9-10):1356-65. PubMed ID: 10188876
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacology of Catharanthus alkaloids].
Levêque D; Wihlm J; Jehl F
Bull Cancer; 1996 Mar; 83(3):176-86. PubMed ID: 8695919
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibition of K-ras-expressing tumours by a new vinca alkaloid, conophylline, in nude mice.
Umezawa K; Taniguchi T; Toi M; Ohse T; Tsutsumi N; Yamamoto T; Koyano T; Ishizuka M
Drugs Exp Clin Res; 1996; 22(2):35-40. PubMed ID: 8879977
[TBL] [Abstract][Full Text] [Related]
10. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
Lobert S; Vulevic B; Correia JJ
Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
[TBL] [Abstract][Full Text] [Related]
11. Photosensitizing effect of riboflavin, lumiflavin, and lumichrome on the generation of volatiles in soy milk.
Huang R; Kim HJ; Min DB
J Agric Food Chem; 2006 Mar; 54(6):2359-64. PubMed ID: 16536619
[TBL] [Abstract][Full Text] [Related]
12. Photosensitized formation of 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) in DNA by riboflavin.
Kasai H; Yamaizumi Z; Yamamoto F; Bessho T; Nishimura S; Berger M; Cadet J
Nucleic Acids Symp Ser; 1992; (27):181-2. PubMed ID: 1289810
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the new vinca-alkaloid S 12363 alone or in combination with verapamil on a human multidrug resistant renal carcinoma xenograft.
Berlion M; Arvelo F; Leonce S; Bourgeois Y; Rigaudy P; Bizzari JP; Poupon MF
In Vivo; 1993; 7(5):399-405. PubMed ID: 7906553
[TBL] [Abstract][Full Text] [Related]
14. Total synthesis and biological evaluation of jerantinine E.
Frei R; Staedler D; Raja A; Franke R; Sasse F; Gerber-Lemaire S; Waser J
Angew Chem Int Ed Engl; 2013 Dec; 52(50):13373-6. PubMed ID: 24127420
[No Abstract] [Full Text] [Related]
15. Cytotoxicity, cell cycle kinetics and morphonuclear-induced effects of Vinca alkaloid anticancer agents.
Pauwels O; Kiss R; Pasteels JL; Atassi G
J Pharm Pharmacol; 1995 Oct; 47(10):870-5. PubMed ID: 8583358
[TBL] [Abstract][Full Text] [Related]
16. Effect of light intensity and wavelengths on photodegradation reactions of riboflavin in aqueous solution.
Ahmad I; Fasihullah Q; Vaid FH
J Photochem Photobiol B; 2006 Jan; 82(1):21-7. PubMed ID: 16223586
[TBL] [Abstract][Full Text] [Related]
17. The Biological Activity of the Novel Vinca Alkaloids 4-chlorochablastine and 4-chlorochacristine.
Montag G; Stopper H; Ngo QA; Hintzsche H
Curr Cancer Drug Targets; 2019; 19(3):222-230. PubMed ID: 29714145
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of vinca alkaloids and related compounds, Part XCVI. Nitration study of vinblastine-type bisindole alkaloids.
Szabó L; Bölcskei H; Eszter BG; Mák M; Szántay C
Arch Pharm (Weinheim); 2001 Dec; 334(12):399-405. PubMed ID: 11852536
[TBL] [Abstract][Full Text] [Related]
19. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
Gan PP; Kavallaris M
Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
[TBL] [Abstract][Full Text] [Related]
20. Photoproducts and proposed degradation pathway in the riboflavin-sensitised photooxidation of isoproterenol.
Massad WA; Marioli JM; García NA
Pharmazie; 2006 Dec; 61(12):1019-21. PubMed ID: 17283660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
